Lisa Kelly
About Lisa Kelly
Lisa Kelly is the Director, Clinical Scientist at Bristol Myers Squibb, specializing in biomarker development and translational applications in immunology and oncology.
Title
Lisa Kelly is the Director, Clinical Scientist at Bristol Myers Squibb. She is currently serving in this role and has been since November 2021.
Professional Experience
Lisa Kelly has a comprehensive background in clinical science and research. Before her current role, she spent a year as a Senior Clinical Scientist at Bristol Myers Squibb, from 2020 to 2021. Prior to that, she worked as a Clinical Research Scientist at Celgene for three years from 2017 to 2020. Her role as Scientist II at Medivation lasted from 2015 to 2017. She served as a Scientist II and Scientist I at Onyx Pharmaceuticals between 2012 and 2015. Earlier in her career, she was a Postdoctoral Fellow at UCSF for two months in 2011, and a Graduate Student at UCSF from 2005 to 2011. She began her research career as an Undergraduate Student Researcher at McGill University from 2003 to 2005.
Education and Expertise
Lisa Kelly holds a PhD in Biomedical Sciences (Immunology) from the University of California, San Francisco, where she studied from 2005 to 2011. She also holds a Bachelor of Science degree in Microbiology and Immunology from McGill University, completed between 2001 and 2005. Her expertise spans cell-based compound screening, biomarker development, and translational applications in immunology and oncology.
Experience in Hematology and Cellular Therapy
Lisa Kelly has significant industry experience in hematology and cellular therapy. This is part of her extensive background in translational applications and specialized clinical research, which supports her current role at Bristol Myers Squibb.
Background in Immunology and Oncology
Throughout her career, Lisa Kelly has specialized in immunology and oncology. Her work has focused on biomarker development and understanding mechanistic insights, providing a strong foundation for her contributions to clinical science and research in these fields.